A Phase I Study for Intravenous Autologous Mesenchymal Stromal Cell Administration to Patients with Severe Emphysema
This Phase I open-label study evaluated the safety and feasibility of intravenous autologous bone marrow-derived mesenchymal stromal cell (MSC) administration in patients with severe emphysema undergoing lung volume reduction surgery (LVRS). Ten patients were enrolled; bone marrow was collected during the first LVRS to isolate and expand MSCs, followed by
June 26, 2025
No Comments